ClinConnect ClinConnect Logo
Search / Trial NCT03980457

Effects of Exoskeleton-Assisted Gait Training on Functional Rehabilitation Outcomes in Patients With Stroke

Launched by UNIVERSITY OF OKLAHOMA · Jun 6, 2019

Trial Information

Current as of July 09, 2025

Recruiting

Keywords

Stroke Leg Weakness Exoskeleton

ClinConnect Summary

This clinical trial is exploring how using a special robotic device, called an exoskeleton, can help patients who have had a stroke improve their ability to walk and regain strength. The study aims to see if this type of training can lead to better recovery outcomes for patients who are undergoing rehabilitation in a hospital setting. Researchers are currently looking for participants who are between the ages of 65 and 87 and have had a stroke that is confirmed by medical imaging.

To be eligible for the study, participants need to be medically stable and able to stand on their own. They should also be able to give written consent to join the study and have a certain level of mental clarity, as measured by a simple test. However, individuals who cannot communicate effectively, are confused, or have other serious medical issues will not be included. Those who participate can expect to receive specialized training with the exoskeleton while working on their rehabilitation goals in a supportive environment. This trial aims to find out if this innovative approach can make a significant difference in recovery for stroke patients.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. All patients with acute hemorrhagic or ischemic stroke documented clinically and by neuroimaging.
  • 2. Medically stable from a cardio-respiratory stand point so that they can participate in daily therapies.
  • 3. Depressed patients will be included in the study
  • 4. Patients able to stand alone
  • 5. Patients able to provide a written informed consent, from cognitively intact patients (admission Mini Mental Scale Examination \[MMSE\] greater than or equal to 21).
  • Exclusion Criteria:
  • 1. Aphasic patients unable to communicate
  • 2. Confused patients
  • 3. Patients medically unstable
  • 4. Patients unable to stand alone
  • 5. Refusal to provide written informed consent

About University Of Oklahoma

The University of Oklahoma, a leading research institution, is dedicated to advancing healthcare through innovative clinical trials and research initiatives. With a robust network of interdisciplinary experts and state-of-the-art facilities, the university fosters an environment that promotes scientific discovery and the development of new treatments. Its commitment to patient-centered research ensures that clinical trials not only adhere to the highest ethical standards but also aim to address pressing health challenges. By collaborating with various stakeholders, including industry partners and healthcare providers, the University of Oklahoma seeks to translate research findings into tangible benefits for communities, ultimately enhancing the quality of care and improving health outcomes.

Locations

Oklahoma City, Oklahoma, United States

Patients applied

0 patients applied

Trial Officials

Meheroz H Rabadi, MD, MRCPI

Principal Investigator

Affiliate; Oklahoma VA Health Care System

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials